S Jennane, EM Mahtat,
M Ababou, H El Maaroufi… - Cureus, 2022 - ncbi.nlm.nih.gov
Chemotherapy-induced posterior reversible encephalopathy (PRES) syndrome is a rare
event. Its recurrence after reusing the incriminated molecules remains unpredictable. We …